ViiV Healthcare

ViiV Healthcare
Five Moore Drive
Research Triangle Park
North Carolina 27709-3398
Phone: +1 877 ViiVUSA (+1 877 844 8872)Website: https://www.viivhealthcare.com/Careers: viivhealthcare.com/en-gb/careers

Latest news

ViiV Healthcare Announces U.S. FDA Approval of Dovato (dolutegravir/lamivudine) for Adolescents Living with HIV
8 April 2024
ViiV Healthcare Announces US FDA Approval of Triumeq PD, the First Dispersible Single Tablet Regimen Containing Dolutegravir, a Once-Daily Treatment for Children Living with HIV
30 March 2022
ViiV Healthcare Announces US FDA Approval of Cabenuva (cabotegravir, rilpivirine) for Virologically Suppressed Adolescents Living with HIV Who Are 12 Years of Age or Older and Weigh at Least 35 kg
29 March 2022
ViiV Healthcare Announces Label Update for its Long-Acting HIV Treatment, Cabenuva (cabotegravir, rilpivirine), to be Initiated With or Without an Oral Lead-In Period
24 March 2022
ViiV Healthcare Announces US FDA Approval of Cabenuva (cabotegravir, rilpivirine) for Use Every Two Months, Expanding the Label of the First and Only Complete Long-Acting HIV Treatment
1 February 2022
FDA Approves Apretude (cabotegravir extended-release injectable suspension) for HIV Pre-Exposure Prophylaxis (PrEP)
20 December 2021
FDA Grants Priority Review to ViiV Healthcare’s New Drug Application for Cabotegravir Long-Acting for Prevention of HIV
28 September 2021
FDA Approves Cabenuva (cabotegravir and rilpivirine) Long-Acting Injectable HIV Treatment and Vocabria (cabotegravir) Oral HIV Treatment
21 January 2021
ViiV Healthcare Receives FDA Breakthrough Therapy Designation for Investigational, Long-Acting Cabotegravir for HIV prevention
17 November 2020
ViiV Healthcare Announces Investigational Injectable Cabotegravir is Superior to Oral Standard of Care for HIV Prevention in Women
9 November 2020

Drugs Associated with ViiV Healthcare

ViiV Healthcare manufactures, markets and/or distributes more than 19 drugs in the United States. Medications listed here may also be marketed under different names in different countries. Non-US country and region specific information is not available on this page.

Brand/Generic Name	Reviews	Rating
Apretude Generic name: cabotegravir Drug class: integrase strand transfer inhibitor	1 review	9.0 / 10
Cabenuva Generic name: cabotegravir/rilpivirine Drug class: antiviral combinations	19 reviews	7.9 / 10
Combivir Generic name: lamivudine/zidovudine Drug class: antiviral combinations	4 reviews	5.8 / 10
Dovato Generic name: dolutegravir/lamivudine Drug class: antiviral combinations	42 reviews	6.5 / 10
Epivir Generic name: lamivudine Drug class: nucleoside reverse transcriptase inhibitors (NRTIs)	2 reviews	6.0 / 10
Epzicom Generic name: abacavir/lamivudine Drug class: antiviral combinations	5 reviews	10 / 10
Juluca Generic name: dolutegravir/rilpivirine Drug class: antiviral combinations	6 reviews	8.2 / 10
Lexiva Generic name: fosamprenavir Drug class: protease inhibitors
Retrovir Generic name: zidovudine Drug class: nucleoside reverse transcriptase inhibitors (NRTIs)
Rukobia Generic name: fostemsavir Drug class: miscellaneous antivirals
Selzentry Generic name: maraviroc Drug class: chemokine receptor antagonist	3 reviews	7.3 / 10
Tivicay Generic name: dolutegravir Drug class: integrase strand transfer inhibitor	18 reviews	6.8 / 10
Tivicay PD Generic name: dolutegravir Drug class: integrase strand transfer inhibitor	1 review	10 / 10
Triumeq Generic name: abacavir/dolutegravir/lamivudine Drug class: antiviral combinations	112 reviews	8.3 / 10
Triumeq PD Generic name: abacavir/dolutegravir/lamivudine Drug class: antiviral combinations
Trizivir Generic name: abacavir/lamivudine/zidovudine Drug class: antiviral combinations	1 review	9.0 / 10
Viracept Generic name: nelfinavir Drug class: protease inhibitors
Vocabria Generic name: cabotegravir Drug class: integrase strand transfer inhibitor
Ziagen Generic name: abacavir Drug class: nucleoside reverse transcriptase inhibitors (NRTIs)
For ratings, users were asked how effective they found the medicine while considering positive/adverse effects and ease of use (1 = not effective, 10 = most effective).

Discontinued Drugs

Brand/Generic Name	Reviews	Rating
Rescriptor Generic name: delavirdine Drug class: NNRTIs
For ratings, users were asked how effective they found the medicine while considering positive/adverse effects and ease of use (1 = not effective, 10 = most effective).